Liver enzymes and stroke risk in middle-aged german adults

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 508-514

  Weikert, Cornelia ^a,b   Drogan, Dagmar ^a   di Giuseppe, Romina ^a   Fritsche, Andreas ^c   Buijsse, Brian ^a   Nöthlings, Ute ^d   Willich, Stefan N ^b   Berger, Klaus ^e   Boeing, Heiner ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alanine aminotransferase; Cohort study; Enzymes glutamyltransferase; General population; Stroke; Transitoric ischemic attack

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84878112622     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.026     Document Type: Article

References (29)

1. Niemela O., Alatalo P. Biomarkers of alcohol consumption and related liver disease. Scand J Clin Lab Invest 2010, 70:305-312.
2. Steffensen F.H., Sorensen H.T., Brock A., et al. Alcohol consumption and serum liver-derived enzymes in a Danish population aged 30-50 years. Int J Epidemiol 1997, 26:92-99.
3. Hoeksema H.L., de Bock G.H. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients. JFam Pract 1993, 37:268-276.
4. Fraser A., Harris R., Sattar N., et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007, 27:2729-2735.
5. Shimizu Y., Imano H., Ohira T., et al. gamma-Glutamyltranspeptidase and incident stroke among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Stroke 2010, 41:385-388.
6. Schindhelm R.K., Diamant M., Dekker J.M., et al. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006, 22:437-443.
7. Targher G., Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, 191:235-240.
8. Marchesini G., Targher G. Commentary: liver enzymes and the risk of adverse cardiovascular outcomes-the lower, the better?. Int J Epidemiol 2011, 40:1539-1541.
9. Wannamethee S.G., Lennon L., Shaper A.G. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008, 201:168-175.
10. Kim H.C., Kang D.R., Nam C.M., et al. Elevated serum aminotransferase level as a predictor of intracerebral hemorrhage: Korea medical insurance corporation study. Stroke 2005, 36:1642-1647.
11. Ford I., Mooijaart S.P., Lloyd S., et al. The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomes. Int J Epidemiol 2011, 40:1530-1538.
12. Boeing H., Korfmann A., Bergmann M.M. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999, 43:205-215.
13. Bergmann M.M., Bussas U., Boeing H. Follow-up procedures in EPIC-Germany-data quality aspects. European Prospective Investigation into Cancer and Nutrition. Ann Nutr Metab 1999, 43:225-234.
14. Prentice R. Acase-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986, 73:1-11.
15. Weikert C., Stefan N., Schulze M.B., et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008, 118:2555-2562.
16. Weikert C., Berger K., Heidemann C., et al. Joint effects of risk factors for stroke and transient ischemic attack in a German population: the EPIC Potsdam Study. JNeurol 2007, 254:315-321.
17. Cai J., Zeng D. Sample size/power calculation for case-cohort studies. Biometrics 2004, 60:1015-1024.
18. Lunn M., McNeil D. Applying Cox regression to competing risks. Biometrics 1995, 51:524-532.
19. Kalogeropoulos A., Terzis G., Chrysanthopoulou A., et al. Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity. Atherosclerosis 2007, 192:190-196.
20. Yagmur J., Ermis N., Acikgoz N., et al. Elevated serum gamma-glutamyl transferase activity in patients with cardiac syndrome X and its relationship with carotid intima media thickness. Acta Cardiol 2010, 65:515-519.
21. Eroglu S., Sade L.E., Polat E., et al. Association between serum gamma-glutamyltransferase activity and carotid intima-media thickness. Angiology 2011, 62:107-110.
22. Franzini M., Corti A., Martinelli B., et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009, 202:119-127.
23. Yun K.E., Shin C.Y., Yoon Y.S., et al. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis 2009, 205:533-537.
24. Ford E.S., Schulze M.B., Bergmann M.M., et al. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 2008, 31:1138-1143.
25. Niizuma H., Suzuki J., Yonemitsu T., et al. Spontaneous intracerebral hemorrhage and liver dysfunction. Stroke 1988, 19:852-856.
26. Fujii Y., Takeuchi S., Tanaka R., et al. Liver dysfunction in spontaneous intracerebral hemorrhage. Neurosurgery 1994, 35:592-596.
27. Pereira M.A., O'Reilly E., Augustsson K., et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004, 164:370-376.
28. Drogan D., Hoffmann K., Schulz M., et al. Afood pattern predicting prospective weight change is associated with risk of fatal but not with nonfatal cardiovascular disease. JNutr 2007, 137:1961-1967.
29. Sattar N., Murray H.M., Welsh P., et al. Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?. PLoS Med 2009, 6:e1000099.